Weight Loss8 min read·Published August 4, 2026

How Much Does Microdose Tirzepatide Cost?

A patient-first guide to monthly pricing, tablets vs injections, clinician review, and safety questions before starting.

How Much Does Microdose Tirzepatide Cost?

Microdose tirzepatide cost depends on the provider, medication form, pharmacy, and whether clinician follow-up is included. At Chia, tirzepatide tablets and injections are available from $249/month and $299/month, respectively, with microdosing plans available when clinically appropriate. Microdosing is off-label, and compounded tirzepatide is not FDA-approved.

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

How much does microdose tirzepatide usually cost?

Microdose tirzepatide pricing usually depends on four things: the medication form, the pharmacy model, the clinician visit structure, and follow-up support. A lower sticker price can be less useful if it does not include prescription review, clear dosing instructions, shipping, or a way to ask safety questions.

What costs are typically included in a monthly program?

A monthly tirzepatide program may include the online intake, clinician review, medication if prescribed, pharmacy dispensing, supplies, shipping, and follow-up messaging. Some programs bundle these together, while others separate visit fees, medication fees, and shipping.

Why prices vary between brand-name, compounded, tablet, and injection options

Brand-name Mounjaro and Zepbound are FDA-approved tirzepatide products with labeled dosing schedules. Compounded tirzepatide is made for an individual prescription by a compounding pharmacy and is not FDA-approved. FDA states that compounded GLP-1 drugs do not undergo FDA review for safety, effectiveness, or quality before marketing 1.

Form also matters. Injections may have different pharmacy, supply, and shipping needs than tablets. For injectable GLP-1 medications, FDA has warned that improper refrigeration during shipping can affect drug quality and advises patients not to use injectable GLP-1 drugs that arrive warm or without enough refrigeration 1.

What to ask before comparing prices

  • Is a licensed clinician reviewing my medical history before prescribing?
  • Is a prescription required before the medication is dispensed?
  • Is the pharmacy state-licensed?
  • Are medication, shipping, supplies, and follow-up included?
  • Will I have clear instructions and access to clinical questions after delivery?
  • What happens if side effects like nausea, vomiting, diarrhea, or constipation occur?

What does microdosing tirzepatide mean?

Microdosing tirzepatide generally means using a lower-dose or slower-titration approach than standard labeled schedules. It is not a formal FDA-approved dosing category, and there is no single official microdose amount.

How microdosing differs from standard dose escalation

FDA-approved tirzepatide labels use stepwise dose escalation. For Zepbound, the FDA label lists a starting dose of 2.5 mg once weekly for 4 weeks, followed by increases in 2.5 mg steps when clinically appropriate, with maintenance doses of 5 mg, 10 mg, or 15 mg once weekly 2. For Mounjaro, the FDA label also lists 2.5 mg once weekly for 4 weeks as the starting dose, then 5 mg once weekly, with possible 2.5 mg increases after at least 4 weeks on the current dose 3.

Those labeled doses are not instructions for you. They are FDA-label information that a clinician may consider along with your health history, goals, medications, and side effects.

Why some patients ask about lower-dose or slower-titration plans

Patients often ask about lower-dose approaches because GLP-1 and GIP/GLP-1 medications can cause digestive side effects. In tirzepatide obesity trials, the most common adverse events were gastrointestinal, including nausea, diarrhea, and vomiting 4. A clinician may also review whether slower titration could fit a patient’s tolerance, goals, and risk profile.

Why there is no single official microdose amount

Microdosing is a practical term, not a standardized research protocol. Unlike the FDA-approved schedules in the Zepbound and Mounjaro labels, microdosing does not have one evidence-based schedule that applies to every person 2, 3.

What does microdose tirzepatide cost at Chia?

At Chia, tirzepatide plans currently start at $249/month for tablets and $299/month for injections. Microdosing plans are available when clinically appropriate after review by a licensed US provider.

Chia optionFormCurrent starting priceWhat to know
TirzepatideTabletsFrom $249/monthProvider-guided dosing; microdosing plans available when clinically appropriate
TirzepatideInjectionFrom $299/monthProvider-guided dosing; microdosing plans available when clinically appropriate

Here is how treatment works at Chia: you complete a short online health questionnaire, then a licensed US provider reviews your information. If treatment is clinically appropriate, the provider may prescribe compounded tirzepatide through a state-licensed 503A pharmacy. The medication is shipped to your door, and you can message your care team through the patient portal.

A prescription is never guaranteed. Our providers review eligibility, medical history, current medications, goals, and safety factors before prescribing.

3-min quiz

See if tirzepatide may fit your goals

Chia offers tirzepatide tablets and injections, with microdosing plans available when clinically appropriate. A licensed US provider reviews your online intake and prescribes only when clinically appropriate; a prescription is not guaranteed. Compounded drugs are not FDA-approved.

Is microdose tirzepatide cheaper than standard tirzepatide?

Microdose tirzepatide may cost less in some programs, but price does not depend only on dose. The total monthly cost can also depend on form, pharmacy model, visit fees, shipping, supplies, and follow-up.

It can be risky to stretch medication or change injection amounts without clinician guidance. FDA has reported dosing errors with compounded injectable semaglutide and adverse event reports related to compounded semaglutide or tirzepatide doses beyond FDA-approved labeling 1.

Option at ChiaFormCurrent starting priceBest fit to discuss with a clinician
TirzepatideTabletsFrom $249/monthPatients who prefer a non-injection form and are eligible after review
TirzepatideInjectionFrom $299/monthPatients for whom an injectable plan is appropriate after review
SemaglutideInjectionFrom $249/monthPatients comparing GLP-1 receptor agonist options
Weight + EnergyNAD+ injection + choice of GLP-1From $309/monthPatients discussing weight management plus energy-focused support
Weight + MuscleSermorelin injection + choice of GLP-1From $329/monthPatients discussing weight management plus muscle-focused support

How much tirzepatide should someone inject for microdosing?

Tirzepatide injection amounts should be individualized by a licensed prescriber. This article cannot safely tell you how much to inject, because dosing depends on medical history, medication strength, syringe markings, side effects, and treatment goals.

What we can say is this: FDA-approved schedules exist for brand-name tirzepatide products, but microdosing does not have a standardized FDA-approved schedule. FDA has also warned about dosing errors with compounded injectable GLP-1 medications, including errors tied to measuring doses from vials 1.

Dosing topicWhat is knownPatient-safe takeaway
FDA-approved Zepbound dosingThe FDA label lists 2.5 mg once weekly for 4 weeks as the starting dose, followed by stepwise titration when clinically appropriate 2.Use label information for education, not self-dosing.
FDA-approved Mounjaro dosingThe FDA label lists 2.5 mg once weekly for 4 weeks as the starting dose, then 5 mg once weekly, with possible increases after at least 4 weeks 3.A clinician should decide whether tirzepatide is appropriate.
MicrodosingNo single FDA-approved microdose schedule exists.Do not choose your own microdose or stretch medication without clinician guidance.
Compounded injectable GLP-1sFDA has reported dosing errors and concerns with compounded injectable GLP-1 medications 1.Ask for clear written instructions and confirm the exact syringe measurement.

What patients can safely ask their prescriber

  • What dose and schedule are you prescribing for me, and why?
  • How should I measure the dose with the supplies provided?
  • What side effects should make me pause and contact the care team?
  • How will we decide whether to adjust the plan?
  • What should I do if I miss a dose, spill medication, or receive a damaged shipment?

Who may not be eligible for tirzepatide?

Tirzepatide is not right for everyone. A clinician may decide against prescribing based on medical history, pregnancy status, current medicines, side effects, or risks listed in FDA labeling.

The Zepbound label includes a boxed warning about thyroid C-cell tumors observed in rats and states that Zepbound is contraindicated in people with a personal or family history of medullary thyroid carcinoma or in people with Multiple Endocrine Neoplasia syndrome type 2 2. The label also warns about risks including pancreatitis, gallbladder disease, hypoglycemia when used with insulin or insulin secretagogues, acute kidney injury, severe gastrointestinal disease, hypersensitivity reactions, diabetic retinopathy complications in patients with type 2 diabetes, and suicidal behavior or ideation 2.

The Mounjaro label includes similar contraindications for medullary thyroid carcinoma history, MEN2, and serious hypersensitivity to tirzepatide or its ingredients 3. This is why eligibility depends on individualized clinical review rather than a simple online price comparison.

What should patients know about compounded tirzepatide safety?

Compounded tirzepatide safety starts with the basics: a valid prescription, a licensed clinician, and a state-licensed pharmacy. FDA recommends that patients obtain compounded GLP-1 medications only with a prescription from a doctor and fill them at a state-licensed pharmacy 1.

FDA also lists telehealth red flags. These include sellers that do not require screening and a prescription by a licensed doctor, do not have a licensed doctor available for questions after medication arrives, offer prices that seem too good to be true, or send products with broken packaging, no instructions, or unexpected appearance 1.

  • Confirm that a licensed clinician reviews your history before prescribing.
  • Confirm that the medication comes from a state-licensed pharmacy.
  • Ask how the medication should be stored during and after shipping.
  • Check that the label, concentration, dose instructions, and supplies match the clinician’s instructions.
  • Contact the care team or pharmacy if anything arrives warm, damaged, unlabeled, or confusing.

How does tirzepatide compare with semaglutide for cost and weight loss evidence?

Tirzepatide and semaglutide work through related but different pathways. Tirzepatide is a dual GIP/GLP-1 receptor agonist, while semaglutide is a GLP-1 receptor agonist; both affect appetite regulation and delayed gastric emptying 2, 7.

In SURPASS-2, tirzepatide 10 mg and 15 mg produced greater A1c reduction and weight loss than semaglutide 1 mg over 40 weeks in adults with type 2 diabetes 5. In a 52-week US payer-perspective cost-effectiveness analysis using SURPASS-2 data, tirzepatide 10 mg had higher total cost and greater A1c and weight reduction than semaglutide 1 mg; the incremental cost-effectiveness ratios were $2,247 per additional 1% A1c reduction and $237 per additional kilogram of weight loss 6. Individual results vary, and these data do not establish outcomes for compounded formulations.

For chronic weight management, the SURMOUNT-1 trial studied once-weekly tirzepatide 5 mg, 10 mg, and 15 mg in adults with obesity or overweight without diabetes and found greater mean percentage weight reduction than placebo over 72 weeks, with gastrointestinal events as the most common adverse events 4. For semaglutide, the STEP 1 trial studied semaglutide 2.4 mg once weekly in adults with overweight or obesity without diabetes and found greater mean weight reduction than placebo over 68 weeks, with nausea and diarrhea common 7.

At Chia, semaglutide injection currently starts at $249/month and may be an alternative for some patients. Our providers can help compare tirzepatide, semaglutide, and protocols like Weight + Energy or Weight + Muscle when clinically appropriate.

How can patients start a clinician-reviewed tirzepatide plan?

To start with Chia, complete the online eligibility quiz in a few minutes. A licensed US provider reviews your health information and prescribes only when clinically appropriate.

  1. 1Complete Chia’s online quiz.
  2. 2A licensed US provider reviews your intake, health history, and goals.
  3. 3If clinically appropriate, the provider may prescribe tirzepatide tablets or injections.
  4. 4Medication is compounded by a state-licensed US 503A pharmacy and shipped to your door.
  5. 5You can message your care team through the patient portal between visits.

If you use an AI agent to manage care tasks, Chia can also be reached through DoctorMCP at mcp.chia.health. The same clinical rule applies: a prescription requires a licensed-provider review and is not guaranteed.

3-min quiz

Start with a licensed-provider review

Chia offers tirzepatide tablets from $249/month and injections from $299/month through our tirzepatide program. Microdosing plans are available when clinically appropriate. A prescription requires medical evaluation and is not guaranteed; compounded drugs are not FDA-approved.

FAQ


References

  1. 1.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2026.
  2. 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) Injection Prescribing Information. 2025.
  3. 3.U.S. Food and Drug Administration. Mounjaro (tirzepatide) Injection Prescribing Information. 2025.
  4. 4.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
  5. 5.Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021.
  6. 6.Sattar N, McGuire DK, Pavo I, et al. Short-term cost-effectiveness analysis of tirzepatide for the treatment of type 2 diabetes in the United States. Journal of Managed Care & Specialty Pharmacy. 2023.
  7. 7.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
  8. 8.U.S. Food and Drug Administration. BeSafeRx: Your Source for Online Pharmacy Information. 2025.

About this article

Chia Health Editorial TeamEvidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides
How Much Does Microdose Tirzepatide Cost? | Chia